Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure

2003 ◽  
Vol 145 (3) ◽  
pp. E14 ◽  
Author(s):  
V. Mitrovic ◽  
R. Willenbrock ◽  
M. Miric ◽  
P. Seferovic ◽  
J. Spinar ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Treatment Effects ◽  
Candesartan Cilexetil ◽  
Clinical Symptoms

scholarly journals Improvement in Exercise Tolerance and Symptoms of Congestive Heart Failure During Treatment With Candesartan Cilexetil

Circulation ◽  
1999 ◽  
Vol 100 (22) ◽  
pp. 2224-2230 ◽  
Author(s):  
G.A.J. Riegger ◽  
H. Bouzo ◽  
P. Petr ◽  
J. Münz ◽  
R. Spacek ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Exercise Tolerance ◽  
Candesartan Cilexetil

scholarly journals Zinc Phosphide Poisoning

2014 ◽  
Vol 2014 ◽  
pp. 1-3 ◽  
Author(s):  
Erdal Doğan ◽  
Abdulmenap Güzel ◽  
Taner Çiftçi ◽  
İlker Aycan ◽  
Feyzi Çelik ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Intensive Care ◽  
Clinical Symptoms ◽  
Treatment Resistance ◽  
Zinc Phosphide ◽  
The Body ◽  
Care Process ◽  
Circulatory Collapse ◽  
Case Presentation

Zinc phosphide has been used widely as a rodenticide. Upon ingestion, it gets converted to phosphine gas in the body, which is subsequently absorbed into the bloodstream through the stomach and the intestines and gets captured by the liver and the lungs. Phosphine gas produces various metabolic and nonmetabolic toxic effects. Clinical symptoms are circulatory collapse, hypotension, shock symptoms, myocarditis, pericarditis, acute pulmonary edema, and congestive heart failure. In this case presentation, we aim to present the intensive care process and treatment resistance of a patient who ingested zinc phosphide for suicide purposes.

scholarly journals Balloon valvuloplasty in two dogs with aortic valve stenosis showing congestive heart failure

2020 ◽  
Vol 65 (No. 2) ◽  
pp. 89-94
Author(s):  
T Yoshida ◽  
K Matsuura ◽  
S Goya ◽  
D Ma ◽  
K Shimada ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Aortic Valve ◽  
Aortic Valve Stenosis ◽  
Clinical Symptoms ◽  
Aortic Flow ◽  
Balloon Valvuloplasty ◽  
Balloon Aortic Valvuloplasty ◽  
Aortic Valvuloplasty ◽  
Key Factor

A 10-year-old female Papillon and a 1-year-old male Golden Retriever were presented to the Tokyo University of Agriculture and Technology for a second opinion on an aortic valve stenosis (AS). The aortic flow rate was not as high as it should have been (the aortic flow velocity for case 1 and case 2 was 2.82 m/s and 3.96 m/s, respectively). However, the AS was suspected to be an exacerbating factor in the congestive heart failure, so that a balloon valvuloplasty was conducted. As a result, the congestion and clinical symptoms were much improved in both cases. In conclusion, in cases with an AS, in which afterload is a key factor for the exacerbation of the congestion, a balloon aortic valvuloplasty may reduce the afterload and consequently lead to an improvement in the congestion.

Sign in / Sign up

Export Citation Format

Share Document